Vermillion Inc. | Mutual Funds
Mutual Funds that own Vermillion Inc.
Fidelity Select Biotechnology Portfolio
1,379,209
1.83%
-1,448,129
0.01%
07/31/2018
Vanguard Total Stock Market Index Fund
823,255
1.09%
0
0%
07/31/2018
Vanguard Extended Market Index Fund
360,988
0.48%
0
0%
07/31/2018
Fidelity Advisor Biotechnology Fund
330,220
0.44%
-335,599
0.01%
07/31/2018
Fidelity Spartan Extended Market Index Fund
170,759
0.23%
0
0%
07/31/2018
iShares Micro Cap ETF
93,966
0.13%
0
0.01%
09/06/2018
Vanguard Institutional Total Stock Market Index Fund
38,754
0.05%
0
0%
07/31/2018
Fidelity Nasdaq Composite Index
26,233
0.04%
0
0%
07/31/2018
iShares Core S&P Total US Stock Market ETF
13,518
0.02%
0
0%
09/06/2018
Fidelity Spartan Total Market Index Fund
12,449
0.02%
0
0%
07/31/2018
| Address |
12117 Bee Caves Road
Austin Texas 78738
United States
|
|
Employees
|
- |
| Website |
http://www.vermillion.com |
| Updated |
07/08/2019 |
| Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. The company's bio-analytical solutions helps physicians diagnose, treat and improve gynecologic health outcomes for women. |
